Saving a hopeless tooth with a four-wall bone defect: A case report.

Takayoshi Nagahara1,2, Tomoyuki Iwata2, Keinoshin Wada3

  • 1Department of Dental, Nippon Kokan Fukuyama Hospital, Fukuyama, Japan.

PubMed
Summary

Recombinant human fibroblast growth factor-2 (rhFGF-2) combined with beta-tricalcium phosphate (β-TCP) shows promise for treating four-wall periodontal bone defects. This combination therapy aids in periodontal regeneration and tooth preservation.

Related Concept Videos